Avecho completes Phase 3 insomnia trial treatment
Avecho Biotechnology (ASX:AVE) completed the treatment phase for its Phase 3 insomnia trial, keeping interim analysis results on track for late June.
Todas as matérias desta categoria, das mais recentes às mais antigas.
Avecho Biotechnology (ASX:AVE) completed the treatment phase for its Phase 3 insomnia trial, keeping interim analysis results on track for late June.
OncoSil Medical (ASX:OSL) shares surge as the TGA approves its Class III pancreatic cancer device for commercialisation in Australia.
Fertility provider Monash IVF Group (ASX:MVF) announced the appointment of Dr Fleur Cattrall as its inaugural Chief Medical Officer.
Biotech firm Patrys (ASX:PAB) announced two key appointments for its upcoming Phase 1A clinical trial of RLS-2202.
Nyrada (ASX:NYR) received a notice of allowance from the United States Patent and Trademark Office for its patent application covering Xolatryp.
BCAL Diagnostics (ASX:BDX) expands its cancer detection reach, integrating clinical referral forms into software used by 97% of Australian GPs.
BlinkLab (ASX:BB1) announced a landmark academic research agreement with the Erasmus University Medical Centre Rotterdam.
Amplia Therapeutics (ASX:ATX) initiated the first stage of a registration-enabling Phase 2b clinical trial for its drug candidate, narmafotinib.
Telix Pharmaceuticals (ASX:TLX) completed patient enrolment for its international, multicentre Phase 1 IPAX-2 clinical trial.
Alcidion Group (ASX:ALC) signed an asset sale agreement to acquire the business and assets of the 'Kyra flow products' from Telstra Health.
Racura Oncology (ASX:RAC) announced a milestone in its Phase 1 CPACS clinical trial, receiving formal clearance to escalate the dosage of its lead candidate, RC220.
AVITA Medical (ASX:AVH) reported its financial performance for the first quarter of 2026, headlined by a total revenue of US$19.3 million.
Tem um segundo para um cookie? 🍪Os cookies essenciais mantêm a Grafa funcionando bem. Alguns opcionais nos ajudam a ver o que está funcionando para melhorarmos. Você tem o controle — pode mudar de ideia quando quiser. Política de cookies · Política de privacidade